Attached files
| file | filename |
|---|---|
| EX-23.2 - EX-23.2 - WCG Clinical, Inc. | d108549dex232.htm |
| S-1/A - AMENDMENT NO. 2 TO FORM S-1 - WCG Clinical, Inc. | d108549ds1a.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement No. 333-257611 on Form S-1 of our report dated May 11, 2021 (June 17, 2021 as it relates to Note 9 to the financial statements and, July 27, 2021 as to the effects of the stock split discussed in Note 9 to the financial statements), relating to the financial statements of WCG Clinical, Inc. and subsidiaries. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Deloitte & Touche LLP
Parsippany, New Jersey
August 2, 2021